Trial · NCT01597258
Adverse events759
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 759
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dysgeusia | Nervous system disorders | XALKORI Capsules (Crizotinib) | 339 | 2,028 | |
| other | Decreased appetite | Metabolism and nutrition disorders | XALKORI Capsules (Crizotinib) | 210 | 2,028 | |
| other | White blood cell count decreased | Investigations | XALKORI Capsules (Crizotinib) | 109 | 2,028 | |
| other | Blood creatinine increased | Investigations | XALKORI Capsules (Crizotinib) | 190 | 2,028 | |
| other | Neutrophil count decreased | Investigations | XALKORI Capsules (Crizotinib) | 166 | 2,028 | |
| other | Blood alkaline phosphatase increased | Investigations | XALKORI Capsules (Crizotinib) | 115 | 2,028 | |
| other | Aspartate aminotransferase increased | Investigations | XALKORI Capsules (Crizotinib) | 271 | 2,028 | |
| other | Alanine aminotransferase increased | Investigations | XALKORI Capsules (Crizotinib) | 291 | 2,028 | |
| other | Liver disorder | Hepatobiliary disorders | XALKORI Capsules (Crizotinib) | 145 | 2,028 | |
| other | Hepatic function abnormal | Hepatobiliary disorders | XALKORI Capsules (Crizotinib) | 249 | 2,028 | |
| other | Pyrexia | General disorders | XALKORI Capsules (Crizotinib) | 118 | 2,028 | |
| other | Oedema peripheral | General disorders | XALKORI Capsules (Crizotinib) | 118 | 2,028 | |
| other | Vomiting | Gastrointestinal disorders | XALKORI Capsules (Crizotinib) | 326 | 2,028 | |
| other | Nausea | Gastrointestinal disorders | XALKORI Capsules (Crizotinib) | 633 | 2,028 | |
| other | Diarrhoea | Gastrointestinal disorders | XALKORI Capsules (Crizotinib) | 500 | 2,028 | |
| other | Constipation | Gastrointestinal disorders | XALKORI Capsules (Crizotinib) | 299 | 2,028 | |
| other | Visual impairment | Eye disorders | XALKORI Capsules (Crizotinib) | 195 | 2,028 | |
| other | Photopsia | Eye disorders | XALKORI Capsules (Crizotinib) | 384 | 2,028 | |
| other | Anaemia | Blood and lymphatic system disorders | XALKORI Capsules (Crizotinib) | 78 | 2,028 | |
| other | Coagulopathy | Blood and lymphatic system disorders | XALKORI Capsules (Crizotinib) | 1 | 2,028 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01597258/events